iSpecimen Inc. (ISPC) Stock Analysis & Investment Frameworks
iSpecimen Inc. (ISPC) stock analysis on Invetso. Review iSpecimen Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
iSpecimen Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Medical - Diagnostics & Research
- Country: US
iSpecimen Inc. Key Financial Metrics
- Market Cap: $204127.00
- Revenue: $1.93M
- ROE: -524.37%
- ROIC: -476.39%
- Dividend Yield: N/A
About iSpecimen Inc.
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.
iSpecimen Inc. Investment Frameworks
Invetso analyzes iSpecimen Inc. (ISPC) across the following frameworks:
- iSpecimen Inc. 10Y Growth Potential
- iSpecimen Inc. Scenario Analysis
- iSpecimen Inc. Risks & Opportunities
- iSpecimen Inc. Economic Moat
- iSpecimen Inc. Business Model
- iSpecimen Inc. Management
- iSpecimen Inc. SWOT Analysis
- iSpecimen Inc. Porter's 5 Forces
- iSpecimen Inc. PESTLE Analysis
- iSpecimen Inc. ESG Analysis
